2023 Q1 Form 10-Q Financial Statement

#000095017023018309 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $71.76M $66.05M
YoY Change 8.64% 41.56%
Cost Of Revenue $17.45M $17.10M
YoY Change 2.01% 84.9%
Gross Profit $54.31M $48.95M
YoY Change 10.96% 30.84%
Gross Profit Margin 75.69% 74.11%
Selling, General & Admin $50.55M $48.49M
YoY Change 4.25% 49.57%
% of Gross Profit 93.07% 99.06%
Research & Development $20.85M $20.94M
YoY Change -0.47% 54.74%
% of Gross Profit 38.38% 42.79%
Depreciation & Amortization $2.904M $2.826M
YoY Change 2.76% 303.71%
% of Gross Profit 5.35% 5.77%
Operating Expenses $77.97M $85.13M
YoY Change -8.41% 85.25%
Operating Profit -$23.66M -$36.18M
YoY Change -34.61% 323.54%
Interest Expense $722.0K -$587.0K
YoY Change -223.0% -5970.0%
% of Operating Profit
Other Income/Expense, Net $31.00K -$156.0K
YoY Change -119.87% 1014.29%
Pretax Income -$21.92M -$36.92M
YoY Change -40.62% 332.14%
Income Tax $197.0K $115.0K
% Of Pretax Income
Net Earnings -$22.12M -$37.04M
YoY Change -40.28% 333.49%
Net Earnings / Revenue -30.83% -56.07%
Basic Earnings Per Share -$0.30 -$0.51
Diluted Earnings Per Share -$0.30 -$511.0K
COMMON SHARES
Basic Shares Outstanding 74.12M 72.47M
Diluted Shares Outstanding 74.14M 72.48M

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $282.3M $376.1M
YoY Change -24.93% 80.82%
Cash & Equivalents $61.07M $250.9M
Short-Term Investments $221.3M $125.2M
Other Short-Term Assets $21.60M $16.14M
YoY Change 33.82% 42.81%
Inventory
Prepaid Expenses
Receivables $59.01M $41.00M
Other Receivables $0.00 $0.00
Total Short-Term Assets $362.9M $433.2M
YoY Change -16.23% 76.55%
LONG-TERM ASSETS
Property, Plant & Equipment $10.25M $7.980M
YoY Change 28.46% -55.91%
Goodwill $49.75M
YoY Change
Intangibles $25.55M
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.614M $6.710M
YoY Change 13.47% 24.26%
Total Long-Term Assets $98.56M $101.8M
YoY Change -3.15% 334.91%
TOTAL ASSETS
Total Short-Term Assets $362.9M $433.2M
Total Long-Term Assets $98.56M $101.8M
Total Assets $461.5M $535.0M
YoY Change -13.74% 99.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.508M $7.924M
YoY Change -5.25% 68.6%
Accrued Expenses $4.239M $40.62M
YoY Change -89.56% 123.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $77.36M $64.81M
YoY Change 19.37% 61.61%
LONG-TERM LIABILITIES
Long-Term Debt $338.0M $336.0M
YoY Change 0.58%
Other Long-Term Liabilities $478.0K $24.30M
YoY Change -98.03% 81.37%
Total Long-Term Liabilities $338.5M $336.0M
YoY Change 0.73% 2407.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $77.36M $64.81M
Total Long-Term Liabilities $338.5M $336.0M
Total Liabilities $427.1M $425.1M
YoY Change 0.45% 694.64%
SHAREHOLDERS EQUITY
Retained Earnings -$552.1M
YoY Change
Common Stock $587.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.44M $109.9M
YoY Change
Total Liabilities & Shareholders Equity $461.5M $535.0M
YoY Change -13.74% 99.04%

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$22.12M -$37.04M
YoY Change -40.28% 333.49%
Depreciation, Depletion And Amortization $2.904M $2.826M
YoY Change 2.76% 303.71%
Cash From Operating Activities -$20.84M -$21.99M
YoY Change -5.23% 72.32%
INVESTING ACTIVITIES
Capital Expenditures $1.063M -$1.340M
YoY Change -179.33% 179.17%
Acquisitions
YoY Change
Other Investing Activities -$8.614M -$23.47M
YoY Change -63.3% 27.78%
Cash From Investing Activities -$9.677M -$24.81M
YoY Change -61.0% 31.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -330.0K 184.0K
YoY Change -279.35% -89.43%
NET CHANGE
Cash From Operating Activities -20.84M -21.99M
Cash From Investing Activities -9.677M -24.81M
Cash From Financing Activities -330.0K 184.0K
Net Change In Cash -30.84M -46.61M
YoY Change -33.83% 56.05%
FREE CASH FLOW
Cash From Operating Activities -$20.84M -$21.99M
Capital Expenditures $1.063M -$1.340M
Free Cash Flow -$21.90M -$20.65M
YoY Change 6.07% 68.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2013-02-28
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001626450
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
BigCommerce Holdings, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2707656
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
11305 Four Points DriveBuilding II, Suite 100
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39423
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78726
CY2023Q1 dei City Area Code
CityAreaCode
512
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
865-4500
CY2023Q1 dei Security12b Title
Security12bTitle
Series 1 common stock, $0.0001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
BIGC
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
74549845
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61070000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91573000
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1117000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1457000
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
221272000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
211941000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
59009000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51899000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14048000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11206000
CY2023Q1 bigc Deferred Commissions Current
DeferredCommissionsCurrent
6431000
CY2022Q4 bigc Deferred Commissions Current
DeferredCommissionsCurrent
6171000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
362947000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
374247000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10251000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9083000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5395000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5887000
CY2023Q1 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
886000
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
470000
CY2023Q1 bigc Deferred Commissions Noncurrent
DeferredCommissionsNoncurrent
6728000
CY2022Q4 bigc Deferred Commissions Noncurrent
DeferredCommissionsNoncurrent
7037000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25550000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
27583000
CY2023Q1 us-gaap Goodwill
Goodwill
49749000
CY2022Q4 us-gaap Goodwill
Goodwill
49749000
CY2023Q1 us-gaap Assets
Assets
461506000
CY2022Q4 us-gaap Assets
Assets
474056000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7508000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7013000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4239000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2937000
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
20786000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
17783000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2509000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20944000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2609000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
42316000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
48444000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
77358000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
78786000
CY2023Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1879000
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1759000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
337989000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
337497000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9362000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10008000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
478000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
334000
CY2023Q1 us-gaap Liabilities
Liabilities
427066000
CY2022Q4 us-gaap Liabilities
Liabilities
428384000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
7000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
587022000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
576851000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-482000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1199000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-552107000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-529987000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
34440000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
45672000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
461506000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
474056000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71757000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66050000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
17446000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
17103000
CY2023Q1 us-gaap Gross Profit
GrossProfit
54311000
CY2022Q1 us-gaap Gross Profit
GrossProfit
48947000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
34052000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
33639000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20845000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16494000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15846000
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
4125000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-22120000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-37037000
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
12660000
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
420000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2033000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2037000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
77969000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
85126000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-23658000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-36179000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2426000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
122000
CY2023Q1 us-gaap Interest Expense
InterestExpense
722000
CY2022Q1 us-gaap Interest Expense
InterestExpense
709000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-156000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21923000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36922000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
197000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
115000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-22120000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-37037000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74142000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74142000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72476000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72476000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-22120000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-37037000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
717000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-613000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21403000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37650000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
45672000
CY2023Q1 bigc Stock Issued During Period Value Stock Options Exercise Net Of Shares Withheld For Taxes
StockIssuedDuringPeriodValueStockOptionsExerciseNetOfSharesWithheldForTaxes
-316000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10487000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
717000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-22120000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
34440000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
138288000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
277000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8962000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-613000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-37037000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
109877000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2904000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2826000
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
493000
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
488000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
10487000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8962000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1075000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1313000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8185000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2502000
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4235000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
806000
CY2023Q1 bigc Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
-49000
CY2022Q1 bigc Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
658000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
495000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-287000
CY2023Q1 bigc Increase Decrease In Accrued And Other Current Liabilities
IncreaseDecreaseInAccruedAndOtherCurrentLiabilities
-4922000
CY2022Q1 bigc Increase Decrease In Accrued And Other Current Liabilities
IncreaseDecreaseInAccruedAndOtherCurrentLiabilities
5702000
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3123000
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
14000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20836000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21985000
CY2023Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
1063000
CY2022Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
1340000
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
39429000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9000000
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
48043000
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
32473000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9677000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24813000
CY2023Q1 bigc Payments For Proceeds From Settlement Of Equity Based Awards
PaymentsForProceedsFromSettlementOfEquityBasedAwards
330000
CY2022Q1 bigc Payments For Proceeds From Settlement Of Equity Based Awards
PaymentsForProceedsFromSettlementOfEquityBasedAwards
-184000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-330000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
184000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-30843000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-46614000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
93030000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
298704000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
62187000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
252090000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
431000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
472000
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
152000
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
32000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
65000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
96000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61070000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
250934000
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1117000
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1156000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
62187000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
252090000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires certain financial instruments to be recorded at fair value; requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenue and expenses during the reporting periods. Significant estimates; judgments, and assumptions in these consolidated financial statements include: allocating variable consideration for revenue recognition, constrained revenue; the amortization period for deferred commissions; the allowance for credit losses and a determination of the deferred tax asset valuation allowance. Because of the use of estimates inherent in financial reporting process actual results could differ and the differences could be material to our consolidated financial statements</span></p>
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71757000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66050000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10251000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9083000
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
20100000
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
19900000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9995000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1075000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1476000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9594000
CY2023Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1600000
CY2023Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4400000
CY2023Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
300000
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
2800000
CY2022Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
0.0
CY2023Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
300000
CY2022Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0.0
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
4100000
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
12700000
CY2023Q1 bigc Business Combination Compensation Expense Related To Contingent Compensation
BusinessCombinationCompensationExpenseRelatedToContingentCompensation
4100000
CY2023Q1 bigc First Contingent Compensation Arrangement Payments Over Service Period
FirstContingentCompensationArrangementPaymentsOverServicePeriod
P12M
CY2023Q1 bigc Second Contingent Compensation Arrangement Payments Over Service Period
SecondContingentCompensationArrangementPaymentsOverServicePeriod
P24M
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
We expect to recognize approximately 56% of the remaining performance obligations as revenue in the following 12-month period, and the remaining balance in the periods thereafter.
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.56
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q1 bigc Amortization Of Deferred Sales Commissions Estimated Period
AmortizationOfDeferredSalesCommissionsEstimatedPeriod
P3Y
CY2023Q1 bigc Impairment Of Deferred Commissions
ImpairmentOfDeferredCommissions
0
CY2022 bigc Impairment Of Deferred Commissions
ImpairmentOfDeferredCommissions
0
CY2023Q1 bigc Deferred Sales Commissions
DeferredSalesCommissions
1700000
CY2023Q1 bigc Net Payments On Settlement Of Equity Based Awards
NetPaymentsOnSettlementOfEquityBasedAwards
300000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1400000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1100000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71757000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66050000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9300000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
155000000.0
CY2022Q1 bigc Deferred Sales Commissions
DeferredSalesCommissions
1600000
CY2022Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1100000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
901000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1326000
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
261609000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
280070000
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000.0
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000.0
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
39009000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13459000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25550000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
39009000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11426000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
27583000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
6099000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
7997000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
6308000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3429000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1717000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25550000
CY2023Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2022Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2023Q1 bigc Lease Operating Lease Expiration Year
LeaseOperatingLeaseExpirationYear
2028
CY2023Q1 bigc Operating And Short Term Rent Expense
OperatingAndShortTermRentExpense
900000
CY2022Q1 bigc Operating And Short Term Rent Expense
OperatingAndShortTermRentExpense
1400000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0538
CY2023Q1 bigc Acquisition Related Compensation Current
AcquisitionRelatedCompensationCurrent
28892000
CY2022Q4 bigc Acquisition Related Compensation Current
AcquisitionRelatedCompensationCurrent
24743000
CY2023Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
4385000
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0541
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2306000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2957000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2775000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2528000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2133000
CY2023Q1 bigc Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
718000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13417000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1548000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
11869000
CY2023Q1 bigc Severance And Other Compensation Charges To Be Paid
SeveranceAndOtherCompensationChargesToBePaid
3600000
CY2023Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
200000
CY2023Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1313000
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1887000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7726000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16900000
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
4914000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
42316000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
48444000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
345000000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
345000000
CY2023Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
7011000
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
7503000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
337989000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
337497000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
661378
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.42
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.67
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.042
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10487000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8962000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0090
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0031
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
396000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21069000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17955000

Files In Submission

Name View Source Status
bigc-20230331_cal.xml Edgar Link unprocessable
0000950170-23-018309-index-headers.html Edgar Link pending
0000950170-23-018309-index.html Edgar Link pending
0000950170-23-018309.txt Edgar Link pending
0000950170-23-018309-xbrl.zip Edgar Link pending
bigc-20230331.htm Edgar Link pending
bigc-20230331.xsd Edgar Link pending
bigc-ex31_1.htm Edgar Link pending
bigc-ex31_2.htm Edgar Link pending
bigc-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
bigc-20230331_def.xml Edgar Link unprocessable
bigc-20230331_lab.xml Edgar Link unprocessable
bigc-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bigc-20230331_htm.xml Edgar Link completed
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending